Equities

Pressure Biosciences Inc

PBIO:QBB

Pressure Biosciences Inc

Actions
  • Price (USD)0.2342
  • Today's Change0.004 / 1.80%
  • Shares traded2.18k
  • 1 Year change-76.59%
  • Beta-0.1957
Data delayed at least 15 minutes, as of May 09 2024 20:39 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Pressure BioSciences, Inc. is engaged in providing broadly enabling, high pressure-based solutions for a range of industries, including biotechnology, pharmaceutical, nutraceutical, cosmeceutical, and agrochemical, as well as food and beverage manufacturing. The Company's enabling platform, Pressure Cycling Technology (PCT), utilizes alternating cycles of pressure to control bio-molecular interactions (such as cell lysis and biomolecule extraction) safely and reproducibly. The Company's BaroFold technology platform allows it to enter the bio-pharma contract services and GMP manufacturing equipment sector. It has also developed the scalable and pressure-based UltraShear Technology platform, which allows for the creation of stable nanoemulsions of otherwise immiscible fluids. It also allows for the preparation of homogenized, extended shelf-life or room temperature-stable low-acid liquid foods that cannot be preserved using existing non-thermal technologies.

  • Revenue in USD (TTM)2.27m
  • Net income in USD-29.56m
  • Incorporated1978
  • Employees15.00
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
PBIO:QBB since
announced
Transaction
value
CBH International LLCAnnounced11 Jan 202411 Jan 2024Announced-53.17%--
Data delayed at least 15 minutes, as of May 09 2024 20:39 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Guided Therapeutics Inc98.00k-3.76m3.56m4.00------36.32-0.074-0.0740.0019-0.07030.03890.105115.0824,500.00-138.59-136.13----36.7329.39-3,560.20-3,666.670.1582-12.94----653.8511.4524.40------
Innovative Eyewear Inc1.15m-6.66m3.70m11.00--0.4912--3.21-0.6442-0.64420.10980.43030.21134.0511.33104,770.90-122.17---137.62---10.35---578.18--8.14-2,255.110.00--74.67---17.28------
Sharps Technology Inc0.00-9.84m3.94m3.00--0.4836-----0.7645-0.76450.000.51950.00-------83.30---109.78----------0.8474--0.00-------112.12------
Nuwellis Inc8.90m-19.93m3.96m59.00--2.00--0.4449-8.30-8.302.730.13040.70761.557.04150,762.70-143.62-98.07-216.07-122.4857.4155.22-202.97-230.510.7092-4.75----3.7612.14-55.78--4.61--
ReShape Lifesciences Inc8.68m-11.39m4.10m31.00--0.6161--0.473-3.77-3.771.460.28410.7960.85154.52279,935.50-104.44-136.06-215.93-194.3263.9356.30-131.22-408.361.74--0.00---22.79-0.947475.36---49.29--
Venus Concept Inc76.35m-37.25m4.33m304.00------0.0567-6.86-6.8614.05-2.540.69721.032.30251,164.50-33.83-32.71-50.39-44.0168.3268.16-48.52-48.501.39-3.931.22---23.2628.3114.76---35.08--
Catheter Precision Inc442.00k-71.37m4.37m14.00--0.1913--9.89-25.32-25.320.08063.020.01861.366.4531,571.43-296.70---376.14--93.21---15,966.52--1.67--0.0086--3,057.14---165.67------
Arch Therapeutics Inc115.33k-7.86m4.51m8.00------39.06-4.07-4.070.0509-2.020.06520.0613--14,416.25-444.57-188.28---804.6327.04---6,819.08-26,945.920.042-2.02----383.83---32.35---21.76--
Bioelectronics Corp1.61m-289.82k4.94m9.00------3.07-0.00002-0.000020.00007-0.00066.329.2014.53---113.86-383.59----49.4351.48-18.01-143.480.0099-0.4909----94.01-5.0975.01------
Pressure Biosciences Inc2.27m-29.56m5.00m15.00------2.20-1.70-1.700.1299-1.221.022.289.17151,505.30-1,074.63-643.54----6.8934.75-1,050.30-798.210.0185-0.4182-----13.64-5.0521.52---34.47--
ADM Tronics Unlimited Inc2.85m-716.86k5.15m7.00--4.67--1.81-0.0106-0.01060.04210.01630.97723.854.25---24.62-11.45-38.81-15.7738.4543.73-25.19-15.281.24--0.2902--14.66-0.415993.04------
Nu-Med Plus Inc0.00-125.53k5.43m2.00---------0.0015-0.00150.00-0.00180.00----0.00-269.93-447.69---------------24.11--------3.56------
Heart Test Laboratories Inc18.60k-6.39m5.83m12.00--0.6558--313.71-0.4912-0.49120.00090.13570.00260.0092.531,550.00-89.51---120.71--67.31---34,362.42--4.70-16.410.0547---64.16---31.61------
BIOLASE Inc49.16m-37.62m5.86m157.00------0.1192-37.97-37.9738.540.57261.342.388.68313,146.50-56.30-49.28-115.21-85.8034.0235.27-41.97-50.720.683-6.610.8778--1.451.27-30.39--18.63--
Sigyn Therapeutics Inc0.00-4.15m6.12m5.00---------3.82-3.820.00-2.650.00----0.00-1,266.54-493.15-----------10,223.960.0189-1.20---------41.51------
Sonendo Inc43.87m-60.92m6.34m216.00--0.2013--0.1446-0.6485-0.64850.46670.44720.40722.388.06203,078.70-56.55---74.56--28.05---138.88--1.53-17.040.568--5.30---6.78------
Data as of May 09 2024. Currency figures normalised to Pressure Biosciences Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.